spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  bioengineered 

 HSMN NewsFeed - 4 Feb 2022
Regenerative Patch Technologies Presents Clinical Data Demonstrating Long-Term Survival and Function of an Allogenic Bioengineered Cellular Implant in Patients with Advanced Dry Aged-Related Macular Degeneration
Regenerative Medicine Ophthalmology
 HSMN NewsFeed - 1 Sep 2021
Tyber Medical Receives Largest FDA 510(k) Clearance For Expanded Line Of Anatomical Plating Systems
Devices Orthopaedic FDA
 HSMN NewsFeed - 21 Oct 2020
Tyber Medical Receives FDA Clearance on Foot and Ankle Plating Systems
Devices Orthopaedic FDA
 HSMN NewsFeed - 29 Mar 2019
PolarityTE Announces Richard Hague, Formerly from Sanofi, Genzyme and Recently Anika Therapeutics as Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 12 Mar 2019
Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 28 Jan 2019
First-In-Human Case Using Biostage's Bioengineered Esophageal Implant is Presented at Major Surgical Meeting
Devices Regenerative Medicine
 HSMN NewsFeed - 8 Nov 2018
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 7 Nov 2018
Ms. Ting Li Appointed to Biostage Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 6 Nov 2018
Biostage awarded $1.1 million Phase II NIH SBIR Fast-Track grant to develop Cellspan(TM) Esophageal Implant (CEI) as a novel treatment for pediatric esophageal atresia
Regenerative Medicine
 HSMN NewsFeed - 26 Sep 2018
Aronora's New Blood Clot Treatment Receives FDA Fast Track Designation
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Mar 2018
Tyber Medical Announces the Limited Release of the Sterile Comprehensive Forefoot Procedure Kit
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 7 Aug 2017
Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
Devices Regenerative Medicine
 HSMN NewsFeed - 19 Apr 2017
Advaxis Appoints Anthony Lombardo as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Mar 2017
Biostage Promotes Saverio La Francesca, M.D. to President
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 17 Feb 2017
Biostage Announces Closing of $8.0 Million Public Offering
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 12 Jul 2016
Advaxis Appoints Ranya Dajani as Vice President, Corporate Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Jun 2016
Biostage Files for FDA Orphan Drug Designation for Cellspan(TM) Esophageal Implant
Regenerative Medicine FDA
 HSMN NewsFeed - 29 Jan 2016
Human Regenerative Technologies, LLC (HRT) Announce WoundEx(R) Amniotic Membrane Products Receive Coverage From Novitas Solutions, Inc.
Devices Regenerative Medicine Reimbursement
 HSMN NewsFeed - 19 Nov 2015
AMNIOX Highlights Study Showing Eighty Percent of Patients With Lower-extremity Ulcers Achieve Healing When Treated with NEOX(R) Wound Allograft
Devices Wound Care
 HSMN NewsFeed - 22 Apr 2014
Aperion Biologics, Inc. Granted CE Mark for Z-Lig ACL Replacement Device
Devices Orthopaedic Regulatory
 HSMN NewsFeed - 19 Mar 2014
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Jan 2014
NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara(R) in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Sep 2012
Raptor Pharmaceutical Corp. Expands Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2012
ReVision Optics Introduces Raindrop as Worldwide Brand for Its Inlay to Treat Presbyopia
Devices Ophthalmology
 HSMN NewsFeed - 24 Jul 2012
Histogenics Closes $49 Million Series A Fundraising to Support Commercial Development of Transformational Cartilage Repair Products
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 28 Mar 2012
Raptor Pharmaceutical Corp. Announces the Appointment of Henk Doude van Troostwijk as General Manager of European Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2011
Cook Group Founder William A. Cook Dies at 80
Devices Personnel
 HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Appoints Kathlene L. Powell Vice President, Quality Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2011
Raptor Pharmaceutical Hires Patrick Reichenberger to Lead Commercial Development of DR Cysteamine for Nephropathic Cystinosis
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2010
NovaBone Putty(R) MIS Delivery System Approved by FDA for Orthopedic Surgery
Devices Orthopaedic Surgery FDA
 HSMN NewsFeed - 6 Jul 2010
Three Rivers Pharmaceuticals Announces FDA Approval Of Expanded Labeling of INFERGEN
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jun 2010
Raptor Pharmaceutical Announces License Agreement for Convivia(TM)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 Feb 2010
Study Showed Sculptra(R) Aesthetic Effectively Corrects Nasolabial Folds and Other Facial Wrinkles
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 28 Jan 2010
Aubrey Inc. Receives FDA Clearance for AWBAT Plus
Devices Wound Care FDA
 HSMN NewsFeed - 7 Oct 2009
Study Shows Uterine Artery Embolization Compares Favorably to Laparoscopic Bilateral Occlusion for Treating Uterine Fibroids
Devices Interventional
 HSMN NewsFeed - 30 Sep 2009
Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Aug 2009
BioSphere Medical Announces New Journal Articles Published Discussing Uterine Fibroid Embolization
Devices
 HSMN NewsFeed - 28 Jul 2009
Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Jun 2009
Calcionics Appoints Daniel O. Wilds Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2009
BioSphere Medical Enters into Exclusive Distribution Agreement with Nippon Kayaku for Japanese Market
Devices Distribution
 HSMN NewsFeed - 13 Apr 2009
Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Aug 2008
BioSphere Medical Announces ACOG Practice Bulletin Recommendation of Uterine Artery Embolization as Alternative to Hysterectomy
Devices
 HSMN NewsFeed - 29 Jul 2008
Advaxis Incorporated Receives List of Questions from the U.S. Food and Drug Administration
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Mar 2008
BioSphere Medical Commences Sales of Embosphere(R) Microspheres in the People's Republic of China
Devices Interventional
 HSMN NewsFeed - 14 Feb 2008
BioSphere Medical Names Willard W. Hennemann, Ph.D. Vice President, New Product and Business Development
Devices Personnel
 HSMN NewsFeed - 28 Jan 2008
BioSphere Medical Receives Market Clearance to Sell Embosphere(R) Microspheres in the People's Republic of China
Devices Regulatory
 HSMN NewsFeed - 22 Jan 2008
BioSphere Medical Names Joel B. Weinstein Vice President of Global Marketing and Sales
Devices Personnel
 HSMN NewsFeed - 15 Jan 2008
Study Published in the Journal of Vascular and Interventional Radiology Concludes That Embosphere(R) Microspheres Should Be the Preferred Agent for Uterine Fibroid Embolization When Compared to Boston Scientific's Contour SE(TM) PVA Microspheres
Devices Interventional
 HSMN NewsFeed - 19 Jul 2007
Bioresorbable Collagen Scaffold Placed inside the Heart Revolutionizes Treatment
Devices Interventional Cardiology Regenerative Medicine
 HSMN NewsFeed - 21 Jun 2007
BioSphere Medical Announces Departure of Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 31 May 2007
Advanced BioHealing Closes Second Tranche of Series C Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 8 Feb 2007
Advanced BioHealing Enrolls First Patient in Celaderm(TM) Pilot Venous Leg Ulcer Clinical Trial
Regenerative Medicine Wound Care
 HSMN NewsFeed - 17 Jan 2007
MedicalCV Elects Two Senior Medical Device Executives to Its Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 9 Jan 2007
Healtheuniverse Advances Adult Stem Cell Commercial Applications for Wound Healing and Bioengineered Surgical Products
Regenerative Medicine Wound Care
 HSMN NewsFeed - 9 Nov 2006
BioSphere Medical Receives FDA Approval For QuadraSphere(TM) Microspheres
Devices Interventional FDA
 HSMN NewsFeed - 22 Sep 2006
DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 May 2006
Advanced BioHealing Announces Purchase of Dermagraft(R) and TransCyte(R)
Devices Wound Care Acquisitions
Return to NewsFeed  

 Additional items found! 28

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 28 additional stories matching:
bioengineered
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.